ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

AACI Summarizes Position On New Core Guidelines

May 16, 1980

Obituary: Ellen Tobin, Consultant, Championed Patients’ Needs;

January 10, 2003

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil.

March 9, 1990

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001